New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
09:04 EDTALXAFDA PDUFA Date for Adasuve
The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date for Alexza Pharmaceuticals' New Drug Application (NDA) for ADASUVE for treatment of agitation associated with schizophrenia or bipolar disorder in adults of December 21. 2012.
News For ALXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Alexza Pharmaceuticals has initiated a Phase 2a study of AZ-002 - Staccato alprazolam -, which is being developed for the management of epilepsy in patients with acute repetitive seizures. ARS occurs in a subset of patients with epilepsy who regularly experience breakthrough seizures, despite treatment with a regular regimen of anti-epileptic drugs. Alexza expects to announce results from this study in 1H15.
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use